U.S. flag

An official website of the United States government

NM_000152.5(GAA):c.1004G>A (p.Gly335Glu) AND Glycogen storage disease, type II

Germline classification:
Pathogenic (2 submissions)
Last evaluated:
Jul 11, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000156939.3

Allele description [Variation Report for NM_000152.5(GAA):c.1004G>A (p.Gly335Glu)]

NM_000152.5(GAA):c.1004G>A (p.Gly335Glu)

Gene:
GAA:alpha glucosidase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
17q25.3
Genomic location:
Preferred name:
NM_000152.5(GAA):c.1004G>A (p.Gly335Glu)
HGVS:
  • NC_000017.11:g.80108338G>A
  • NG_009822.1:g.11783G>A
  • NM_000152.5:c.1004G>AMANE SELECT
  • NM_001079803.3:c.1004G>A
  • NM_001079804.3:c.1004G>A
  • NP_000143.2:p.Gly335Glu
  • NP_001073271.1:p.Gly335Glu
  • NP_001073272.1:p.Gly335Glu
  • LRG_673t1:c.1004G>A
  • LRG_673:g.11783G>A
  • NC_000017.10:g.78082137G>A
  • NM_000152.3:c.1004G>A
  • P10253:p.Gly335Glu
Protein change:
G335E
Links:
UniProtKB: P10253#VAR_068589; dbSNP: rs730880022
NCBI 1000 Genomes Browser:
rs730880022
Molecular consequence:
  • NM_000152.5:c.1004G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001079803.3:c.1004G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001079804.3:c.1004G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Glycogen storage disease, type II (GSD2)
Synonyms:
ACID ALPHA-GLUCOSIDASE DEFICIENCY; GLYCOGENOSIS, GENERALIZED, CARDIAC FORM; GSD II; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0009290; MedGen: C0017921; Orphanet: 365; OMIM: 232300

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000206660Medical Genetic Department, Shiraz University Of Medical Science
no assertion criteria provided
Pathogenicgermlineclinical testing

SCV003443317Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Jul 11, 2023)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedgermlinenonot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Clinical and GAA gene mutation analysis in 21 Chinese patients with classic infantile pompe disease.

Su X, Sheng H, Huang Y, Li X, Zhang W, Zhao X, Li C, Liu L.

Eur J Med Genet. 2020 Dec;63(12):103997. doi: 10.1016/j.ejmg.2020.103997. Epub 2020 Jul 22.

PubMed [citation]
PMID:
32711049

Clinical course, mutations and its functional characteristics of infantile-onset Pompe disease in Thailand.

Ngiwsara L, Wattanasirichaigoon D, Tim-Aroon T, Rojnueangnit K, Noojaroen S, Khongkraparn A, Sawangareetrakul P, Ketudat-Cairns JR, Charoenwattanasatien R, Champattanachai V, Kuptanon C, Pangkanon S, Svasti J.

BMC Med Genet. 2019 Sep 11;20(1):156. doi: 10.1186/s12881-019-0878-8.

PubMed [citation]
PMID:
31510962
PMCID:
PMC6737665
See all PubMed Citations (4)

Details of each submission

From Medical Genetic Department, Shiraz University Of Medical Science, SCV000206660.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenonot providednot providednot providednot providednot providednot providednot provided

From Invitae, SCV003443317.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

This missense change has been observed in individual(s) with Pompe disease (PMID: 32711049). For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Gly335 amino acid residue in GAA. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 22644586, 31510962). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. Experimental studies have shown that this missense change affects GAA function (PMID: 22644586). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt GAA protein function. ClinVar contains an entry for this variant (Variation ID: 180142). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces glycine, which is neutral and non-polar, with glutamic acid, which is acidic and polar, at codon 335 of the GAA protein (p.Gly335Glu).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 20, 2024